ABSTRACT: Mechanical ventilation of preterm infants is associated with pulmonary inflammation. Intubated infants often develop bacterial tracheal colonization, but little is known about endotoxin in tracheal aspirates (TAs) or the mobilization of innate immunity toward endotoxin, a potent stimulus that contributes to inflammatory disease. We characterized mobilization of endotoxin-directed innate immunity in TAs from an observational cohort of mechanically ventilated neonates. TA supernatants (n ϭ 42; GA ϭ 23-40 wk, postnatal age ϭ 1-71 d) were assayed for endotoxin (Limulus amoebocyte lysate assay) and endotoxin-modulating proteins: bactericidal/permeability-increasing protein (BPI), LPS-binding protein (LBP), and soluble cell differentiation antigen 14 (sCD14). TA cellular BPI was measured by ELISA, Western blot, flow cytometry, and bactericidal assay. TA mRNAs encoding endotoxin-modulating proteins were measured by quantitative real-time PCR (qRT-PCR). Endotoxin in TA supernatants was proportional to both postnatal age and polymorphonuclear leukocytes (PMN). Neonatal TAs were rich in PMN containing BPI and expressed mRNAs encoding Toll-like receptor (TLR) 4, CD14, and myeloid differentiation protein 2 (MD-2). Extracellular BPI was consistently detectable and correlated with TA PMN and GA. Both extracellular-and cellular-BPI increased during the first postnatal week. TA extracellular BPI, LBP, and sCD14 were positively correlated. TAs from intubated neonates demonstrate endotoxin accumulation and mobilization of endotoxin-directed innate immunity, potentially contributing to pulmonary inflammation. (Pediatr Res 66: 191-196, 2009) 
I
nnate immunity of the newborn is functionally distinct from that of adults (1,2) with respect to the expression of pattern recognition receptors, signaling adaptor proteins, and host defense effector molecules (3) . Innate immunity of newborns to Gram-negative bacteria (GNB) and GNB-derived endotoxin or lipopolysaccharide (LPS) is of interest because 1) GNB are common intestinal commensal flora, 2) GNB are life-threatening neonatal pathogens (4) , and 3) multiple diseases of prematurity are associated with endotoxin including sepsis (5), bronchopulmonary dysplasia (6) , necrotizing enterocolitis (7), and cerebral palsy due to intracranial white matter damage (8) .
Humans are highly sensitive to very low concentrations (picograms/mL) of endotoxin. This reflects efficient and sequential humoral and cell-based protein-endotoxin and protein-protein interactions involving LPS-binding protein (LBP), membrane and soluble forms of CD14, myeloid differentiation protein 2 (MD-2), and toll-like receptor (TLR)-4 (9,10). Sensitivity to endotoxin can be dampened by changes in expression of these proteins (11) as competition with other LBPs precludes transfer of LPS to CD14 and to the MD-2/TLR4 receptor complex on monocytes (12) . Endotoxin induces tracheobronchial epithelial cell production of antimicrobial peptides (13) and cytokines that recruit and activate polymorphonuclear leukocytes (PMN) (14) .
PMN play key roles in innate immunity deploying both oxygen-dependent and independent means to dispose of pathogens and neutralize their toxins (15) . Bactericidal/permeabilityincreasing protein (BPI) is a cationic, 55-kD protein of PMN primary granules that possesses anti-infective activities against GNB: endotoxin neutralization based on high affinity (nM) binding of BPI to the lipid A region of LPS, bactericidal activity via membrane permeabilization, and opsonic activity (16) . Human newborn cord blood PMN are deficient in BPI: full-term neonatal cord blood PMN contain ϳ25-33% of adult PMN BPI (17) , and preterm human cord blood demonstrates impaired stimulusinduced release of extracellular BPI (18) .
Endotoxin could contribute to airway inflammation in mechanically ventilated human newborns by inducing tracheobronchial epithelial cell NF-B activation (19, 20) and consequent production of cytokines or chemokines that recruit or activate PMN (14, 19, 21, 22) . Accordingly, endotoxin instillation in the lungs of mechanically ventilated preterm lambs impairs gas exchange and induces systemic inflammation, mimicking aspects of severe lung disease in preterm humans (23) .
Endogenous protein mediators of innate immunity are expressed in a GA-dependent manner (3,24 -26) . Relative to adults, human newborns are deficient in BPI content of cord blood PMN (17, 18) and serum concentrations of the liverderived acute phase reactants LBP and soluble cell differentiation antigen 14 (sCD14; 3). However, neonatal expression of these LPS-modulating proteins at inflammatory sites, such as tracheal aspirates (TAs), has not been reported. We undertook an observational study to characterize the presence of endotoxin and mobilization of endotoxin-modulating proteins in TAs of critically ill human newborns. We demonstrate endotoxin and early mobilization of endotoxin-directed innate immunity in respiratory secretions of intubated newborns, suggesting a possible role for endotoxin in pulmonary inflammation.
METHODS
Using an institutional review board (IRB)-approved protocol (Partners Human Research Committee), TA samples were collected from mechanically ventilated newborns (n ϭ 42) at the Brigham and Women's Hospital NICU. Informed consent was not required as TAs are discarded specimens. GA ranged from 23 to 40 wk (mean 28), and 70% were male. Preterm neonates were intubated for respiratory failure (surfactant deficiency; n ϭ 38), whereas full-term neonates were intubated for surfactant deficiency (n ϭ 2), pneumonia (n ϭ 1), and persistent pulmonary hypertension (n ϭ 1). TAs were collected after endotracheal instillation of 0.5 mL/kg sterile, pyrogen-free saline using sterile suction catheters and placed on ice for processing within 4 h. Because of TA volume constraints, subsets of samples were analyzed for different markers, with n provided in each figure legend.
Collection of neonatal TAs. After centrifugation (700 g, 7 min at 4°C) and collection of TA supernatants, TA pellets were subjected to hypotonic lysis (sterile, pyrogen-free water; Baxter, Deerfield, IL) to remove erythrocytes (ϳ45 s at 4°C), and 5% saline was added [final (NaCl) ϭ 0.14 M] before washing (Hanks' Balanced Salt Solution without divalent cations). TA PMN were enumerated by microscopy of Wright's stained aliquots (Shandon Cytospin 3; Thermo Fisher Scientific, Waltham, MA), typically demonstrating Ն70% PMN. Cell viability (trypan blue exclusion) was Ն80%. TA pellets and supernatants were stored at Ϫ80°C before batch analysis.
Measurement of endotoxin. Endotoxin was measured using the Limulus amoebocyte lysate (LAL) assay according to the manufacturer's instructions (Charles River, Boston, MA).
PMN isolation. PMN were isolated from adult whole blood by dextran sedimentation and Ficoll-hypaque gradient centrifugation, using pyrogen-free reagents, as previously described (17) , and enumerated by automated cell count and differential (Ն85% pure; ADVIA 2120, Siemens Medical Solutions Diagnostics, Tarrytown, NY), before storage at Ϫ80°C.
Sulfuric acid extraction of PMN BPI. Cell extracts were prepared using sonication and sulfuric acid, as previously described (17) .
Western blotting. PMN acid extracts (5 ϫ 10 5 PMN equivalents/well) were fractionated by SDS-PAGE. Western blotting used anti-BPI goat serum and I 125 protein G as previously described (17) , providing BPI detection in the 10 -200 ng range. rBPI-50, a kind gift from XOMA (US) LLC, was used as BPI standard.
Measurement of soluble BPI, LBP, and CD14. ELISAs for the measurement of BPI and LBP (Hycult Biotechnology, Holland) and sCD14 (R&D Systems, MN) were used according to the manufacturer's instructions.
Total protein measurement. The Bradford protein assay (Bio-Rad Laboratories, Inc. Hercules, CA) was used with human serum albumin as standard.
Antibacterial activity. Activity of PMN acid extracts against the serumresistant BPI-sensitive bacteremic isolate Escherichia coli K1/r, a K1-encapsulated rough LPS chemotype strain, was measured as previously described (17, 27) and expressed as %viability (ratio to input inoculum).
Isolation of RNA. RNA in TA pellets (3 ϫ 10 5 -10 6 TA cells) was purified according to the manufacturer's instructions (RNeasy Plus Mini Kit; Qiagen, Valencia, CA) either immediately or after storage (Ϫ80°C) in RNA Cell Protect Reagent (Qiagen).
Quantitative real-time PCR. cDNA was prepared using the RT 2 First Strand Kit and treated with DNase (Superarray, Frederick, MD) before measurement of relative mRNA abundance by quantitative real-time PCR (qRT-PCR; SuperArray), using an ABI Prism 7000 Sequence Detector (Applied Biosystems, Foster City, CA). RT 2 SYBR Green/ROX qPCR Master Mix was added to cDNA according to the manufacturer's instructions (SuperArray). Expression levels were normalized to housekeeping genes using the ⌬Ct method.
Flow cytometry. Fc binding sites on TA cells were blocked using 10% normal human serum (60 min RT) to prevent nonspecific binding. To detect granulocytes, cells were surface stained (20 min RT) with FITC-conjugated anti-CD66b MAb (mouse IgM, clone G10F5) at 5 L/5 ϫ 10 5 cells or the corresponding FITC-conjugated isotype control (mouse IgM, clone G155-228; BD Pharmingen, San Jose, CA). After washing (Stain Buffer; BD Pharmingen) and permeabilization (1ϫ fluorescence-activated cell sorter lysing solution with 1ϫ permeabilization or wash buffer containing saponin; BD Pharmingen, 10 min RT), BPI was detected by staining (20 mins RT) with anti-BPI MAb (mouse IgG1(), clone HM2042; HyCult Biotechnology, Uden, Holland) or isotype control (mouse IgG1(), clone MOPC-21; BD Pharmingen), followed by incubation (20 min RT) with a secondary phycoerythrin-conjugated MAb (rat anti-mouse IgG1(), clone A85-I; BD Pharmingen) at 5 L/5ϫ10 5 cells. Cells were preserved overnight (1% formalin and stain buffer, 4°C) before analysis by flow cytometry (Cytomation MoFlo flow cytometer) and analyzed with Summit Software (v. 4.3, Dako, CO).
Fluorescent and confocal microscopy. Formalin-fixed cell preparations were imaged on a Nikon TE-2000 inverted microscope fitted with a video-rate confocal system: spinning disk confocal head (Yokogawa, Newnan, GA), Kr/Ar laser illumination source (Melles Griot, Carlsbad, CA), fluorescence filters, and an Orca ERG cooled CCD camera (Hamamatsu, Hamamatsu, Japan). Image capture and 3D rendering used Slidebook software (Intelligent Imaging Innovations, Inc., Denver, CO). Confocal images were collected either as single 2D planes [paired with a differential interference contrast (DIC) view] or as 3D stacks (focal step size 0.3 m).
Statistics. Statistical analyses used Prism 4.0a for MacIntosh (Graphpad Software, Inc., San Diego, CA) and SAS 9.1 (SAS Institute, Inc., Cary, NC). Antibacterial activity of neonatal TA and adult peripheral blood PMN extracts was compared using the unpaired t test. Correlations were drawn using the Pearson or the Spearman method based on normality of the data. The nonparametric Mann-Whitney U test was used for unequal variances (28) .
The p values Յ0.05 were considered significant.
RESULTS
We initially assessed whether endotoxin was detectable in a subset of TA supernatants. Fifteen of 37 (38%) TAs tested positive for endotoxin. Endotoxin concentrations ranged from undetectable (Ͻ0.01) to 2542 endotoxin units per milliliter (EU/mL) and positively correlated with postnatal age (Fig.  1A) . TA PMN also increased with postnatal age (Fig. 1B) and correlated with TA endotoxin concentration (Fig. 1C) .
To determine whether genes encoding endotoxin-modulating proteins are activated in TAs, we measured expression of endotoxin receptor components by qRT-PCR (Fig. 2) . mRNAs encoding TLR4, MD-2, and CD14 were consistently detected (n ϭ 6/6 TAs). In contrast, BPI mRNA was inconsistently (n ϭ 4/6) detected at low levels (Ͻ10-fold ratio to lower limit of detection; not shown), and mRNA encoding the liver-derived acute phase reactant LBP was not detected (n ϭ 0/6).
We next assessed whether BPI protein was detectable in TA pellets (Fig. 3) . Bands corresponding to native BPI in adult PMN extracts were noted in premature neonatal TAs (rightmost lanes in Fig. 3 ) indicating expression of BPI in these samples, albeit at relatively lower amounts. Measurement of TA cellular BPI by ELISA of acid extracts (Fig. 4A) demonstrated mean cellular BPI concentrations of neonatal TA PMN nearly 3-fold lower than those of adult peripheral blood PMN. Accordingly, neonatal TA acid extracts were ϳ3-fold less potent than adult extracts with respect to killing of the BPI-sensitive clinical isolate E. coli K1/r (Fig. 4B) .
To verify the source of BPI, we stained TA cells for the PMN marker CD66b and for intracellular BPI (Fig. 5) . CD66bϩ/BPIϩ cells were readily detected in TAs (Fig. 5B ), and most (Ͼ95%) BPI-positive cells were PMN. Confocal fluorescent and DIC imaging also demonstrated CD66bϩ/BPIϩ cells (Fig. 5G and I) .
We next characterized extracellular BPI expression and its correlates. Extracellular BPI was detectable (Ͼ0.1 ng/mL) in Ͼ98% of TAs (range 4 -7920 ng extracellular BPI/mL TA supernatant). Extracellular BPI positively correlated with TA PMN content (Fig. 6A ) even after adjustment for total protein (TP; Fig. 6B ). Extracellular BPI concentrations in TAs sampled during the first two postnatal days also correlated with GA ( Fig. 6C ) even when adjusted for TP (Fig. 6D) . TA PMN count and GA did not correlate (not shown).
Under basal conditions, most PMN BPI are intracellular and degranulation of BPI can occur during inflammation (29) . We assessed the relative expression of BPI in the cellular and extracellular fractions of neonatal TAs. Cellular BPI (TA pellet extracts) and extracellular BPI (TA supernatants) were measured by ELISA. Data were analyzed after adjusting for both TP content and PMN count. Representative data from a subset of subjects in Fig. 7 demonstrate that the majority (79 -99%) of neonatal TA BPI remained cell associated. TA cells express endotoxin receptor components CD14, TLR4, MD-2, and BPI. TA pellet RNA was analyzed by qRT-PCR. mRNA levels are expressed as mean Ϯ SEM mRNA abundance relative to housekeeping controls as a ratio to the lower limit of detection. mRNA for proteins encoding LPS receptor components TLR4, CD14, and MD-2 were consistently detected (n ϭ 6/6 TAs tested; mean GA ϭ 29 wk). BPI was detected in 4/6 TAs. In contrast, LBP mRNA was not detected (0/6 TAs tested). Extracellular BPI normalized for TP also increased with postnatal age, independently of GA (Fig. 8A) . When the analysis was dichotomized by postnatal age, extracellular BPI adjusted for TP increased significantly over the first postnatal week (Fig. 8B) . Indeed, cellular BPI adjusted for TP and PMN count increased significantly in the first postnatal week (Fig.  8C ). Cellular and extracellular BPI did not correlate (not shown) suggesting that increased cellular BPI content of TA PMN during the first week of life was not secondary to reduced release of extracellular BPI.
LBP and sCD14 were readily detected in neonatal TA supernatants (mean Ϯ SEM: LBP 106 Ϯ 25 ng/mL; sCD14 68 Ϯ 13 ng/mL) and correlated with extracellular BPI. Extracellular BPI positively correlated with LBP ( Fig. 9A) and sCD14 (Fig. 9B) . LBP also positively correlated with sCD14 (Fig. 9C ).
DISCUSSION
We have characterized for the first time the presence of endotoxin and the expression of key endotoxin-modulating proteins in TAs of an observational cohort of mechanically ventilated human infants. We show that endotoxin is present in tracheal secretions, especially after prolonged intubation corresponding to early mobilization of endotoxin-directed innate immunity.
BPI is a key PMN-derived protein mobilized to tracheal secretions. Neonatal TA PMN express BPI antigen of identical molecular weight to that of adults, albeit at lower levels than adult peripheral blood PMN (Figs. 3 and 4) . TA BPI is predominately cell associated (Fig. 7) , consistent with the subcellular localization of BPI to PMN primary granules, which are less prone to extracellular degranulation (30) . However, neonatal TA extracellular BPI was consistently detectable and correlated with TA PMN content (Fig. 6A and B) , suggesting that PMN are the predominant source of BPI in these upper respiratory secretions.
TA BPI expression was both GA and postnatal age dependent: a) extracellular BPI concentrations during the first two postnatal days correlated with GA ( Fig. 6C and D) , b) extracellular BPI adjusted for TP increased with postnatal age (Fig.  8A and B) , and c) cellular BPI adjusted for TP and PMN count specifically increased in the first postnatal week (Fig. 8C) . Postnatal increases in cellular BPI might reflect developmental increases in availability or recruitment of more mature PMN and/or potential transcriptional activation of mature PMN (31) that can up-regulate gene expression (32) .
In addition to substantial TA supernatant concentrations of extracellular BPI (mean ϳ1 g/mL), we also detected substantial amounts of extracellular LBP (0.3-680 ng/mL) and sCD14 (0.5-315 ng/mL), concentrations in the bioactive range (11) . Because TAs were obtained after endotracheal instillation of saline, they represent diluted samples, and true local airway fluid concentrations of these host defense proteins are likely even higher. Extracellular BPI was very likely derived from PMN based on correlation with PMN count (Fig. 6 ), flow cytometry, and confocal microscopy (Fig. 5) . CD14 mRNA was abundant in TA pellets (Fig. 2) , indicating possible local CD14 production, but we do not exclude contribution from a liver-derived acute phase response/plasma exudation (11, 33) . LBP mRNA was not detected in TAs (Fig. 2) , and its presence at the protein level may reflect respiratory epithelial cell production (34) and/or an acute phase response (11, 33) . Positive correlations among extracellular BPI, LBP, and sCD14 in neonatal TA supernatants (Fig. 9 ) demonstrate coordinated mobilization of endotoxin-modulating proteins to the trachea of mechanically ventilated newborns.
Endotoxin (Fig. 1) introduced to the neonatal respiratory tract during peripartum infection and/or on endotracheal tube colonization could induce mobilization of endotoxinmodulating proteins to respiratory secretions. TLR-mediated activation of NF-kB and subsequent cytokine production may contribute to the mobilization of BPI, LBP, and sCD14 to the neonatal respiratory tract (3, 19) . Maturation of pathways mediated by C/EBP epsilon, a transcription factor important for BPI expression (35) , might underlie the postnatal increase in BPI expression. In mice, endotracheal LPS induces an IL-6-mediated acute phase response, including LBP and sCD14 production (33) . Moreover, during the first postnatal week, human newborns demonstrate increasing basal serum concentrations of IL-6 (36), a cytokine that is also detected in neonatal TAs (37) . Consistent with such a mechanism of microbe-induced activation of innate immunity, our study documents that endotoxin is detected in TA supernatants, especially after prolonged intubation, and that multiple endotoxin-modulating proteins are up-regulated after intubation.
Our findings have potential clinical relevance. The magnitude and duration of exposure of the neonatal respiratory tract to endotoxin coupled with individual susceptibility to endotoxin-induced inflammation might contribute to susceptibility of newborns to a variety of endotoxin-associated conditions, as has been found in other settings (38 -40) . Indeed, the early presence of endotoxin likely contributes to recruitment of PMN to the trachea, which has been associated with subsequent chronic lung disease (41) . Our characterization of endotoxin-directed innate immunity in this observational cohort sets the stage for testing such hypotheses in larger cohorts powered to correlate with clinical outcomes. To the extent that endotoxin plays a role in ventilator-associated lung inflammation and disease, potential prophylaxis and/or treatment might be forthcoming in the form of investigational endotoxin antagonists, including recombinant BPI congeners and lipid A antagonists (e.g. E5564), agents that safely reduce endotoxindriven inflammation in human studies in vivo (42) (43) (44) .
